Agios Pharm (AGIO) — Net Asset Quality Index
Agios Pharm (AGIO) has a Net Asset Quality Index of 93.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.18 Billion minus total liabilities of $75.88 Million yields net assets of $1.11 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Agios Pharm (AGIO) defensive interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Agios Pharm Net Asset Quality Index Over Time (2011–2025)
This chart shows how Agios Pharm's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 93.6%, representing net assets of $1.11 Billion against total assets of $1.18 Billion USD. Explore Agios Pharm cash conversion from operations to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Agios Pharm (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Agios Pharm from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Agios Pharm stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | $1.19 Billion | $1.30 Billion | $104.11 Million | ▼ -0.7 pp |
| 2024 | 92.7% | $1.54 Billion | $1.66 Billion | $122.24 Million | ▲ +6.1 pp |
| 2023 | 86.5% | $811.02 Million | $937.12 Million | $126.10 Million | ▼ -2.3 pp |
| 2022 | 88.9% | $1.10 Billion | $1.24 Billion | $137.90 Million | ▼ -1.0 pp |
| 2021 | 89.9% | $1.29 Billion | $1.44 Billion | $145.76 Million | ▲ +43.0 pp |
| 2020 | 46.8% | $399.50 Million | $852.95 Million | $453.45 Million | ▼ -25.1 pp |
| 2019 | 71.9% | $640.53 Million | $890.74 Million | $250.21 Million | ▼ -8.2 pp |
| 2018 | 80.1% | $687.54 Million | $858.46 Million | $170.92 Million | ▲ +19.0 pp |
| 2017 | 61.1% | $375.50 Million | $614.40 Million | $238.89 Million | ▲ +3.2 pp |
| 2016 | 57.9% | $358.59 Million | $619.09 Million | $260.50 Million | ▼ -24.2 pp |
| 2015 | 82.2% | $345.12 Million | $420.06 Million | $74.95 Million | ▼ -4.1 pp |
| 2014 | 86.3% | $424.37 Million | $491.90 Million | $67.54 Million | ▲ +20.9 pp |
| 2013 | 65.3% | $131.48 Million | $201.21 Million | $69.72 Million | ▲ +33.3 pp |
| 2012 | 32.0% | $43.90 Million | $137.01 Million | $93.11 Million | ▼ -0.4 pp |
| 2011 | 32.5% | $63.14 Million | $194.47 Million | $131.33 Million | — |